Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Liberty Live-C
LLYVK
5
American Express
AXP
JP Stock MarketDetailed Quotes
4521 Kaken Pharmaceutical
- 4004.0
- -51.0-1.26%
20min DelayTrading May 8 13:34 JST
183.94BMarket Cap18.83P/E (Static)
4061.0High4004.0Low67.40KVolume4061.0Open4055.0Pre Close271.45MTurnover4901.052wk High0.23%Turnover Ratio45.94MShares3378.052wk Low541.88EPS TTM118.75BFloat Cap12720.0Historical High18.83P/E (Static)29.66MShs Float822.0Historical Low212.67EPS LYR1.41%Amplitude150.00Dividend TTM0.99P/B100Lot Size3.75%Div YieldTTM
About Kaken Pharmaceutical Company
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Company Profile
Symbol4521
Company NameKaken Pharmaceutical
Founded1948-03-01
MarketTSE Prime
Employees1143
Fiscal Year Ends03-31
Address28-8, Honkomagome 2-chome Bunkyo-ku
Zip Code113-8650
Phone03-5977-5001
Websitewww.kaken.co.jp
Company Executives
- Name
- Position
- Salary
- Mitsuru Watanuki
- Director and Chief Officer, Research and Development
- --
- Hiroyuki Horiuchi
- Director and President
- --
- Yasuhiro Umeda
- Director
- --
- Masashi Suzudo
- Director
- --
- Masahiro Matsuura
- Director
- --
- Satoko Ishikawa
- Independent Director
- --
- Yasutomo Inoue
- Independent Director
- --
- Shoichiro Takagi
- Independent Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting